← Open Payments lookup

HANNAH FOLDS: Open Payments

NPI 1922412022 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,092 in 53 payments from 17 companies in 2025. Trend: 2023 $856 · 2024 $1,134 · 2025 $1,092

Food & beverage: $1,092
CompanyPaymentsAmount
Madrigal Pharmaceuticals5$149
Takeda Pharmaceuticals U.S.A., Inc.7$141
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$140
Janssen Biotech, Inc.8$132
Gilead Sciences, Inc.4$98
Ipsen Biopharmaceuticals, Inc4$77
ABBVIE INC.3$66
GENZYME CORPORATION2$47
Lilly USA, LLC2$47
Organon LLC2$37

Products named: REZDIFFRA, XIFAXAN, TREMFYA, ENTYVIO, IQIRVO, DUPIXENT, OMVOH, HADLIMA.

Industry payments across GA — which companies pay providers there.